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The fragmentation of patterns of moxiﬂoxacin, 2-N-methylated moxiﬂoxacin (analog 1),
and 1-cyclopropyl-6,7-diﬂuoro-8-methoxy-4-oxo-3-quinolinecarboxylic acid (analog 2)
were investigated by electrospray ionization quadrupole time-of-ﬂight tandem mass spec-
trometry in the positive-ion mode. Many unusual ions were detected in the tandem mass
spectra of moxiﬂoxacin. Although the structures of moxiﬂoxacin and analog 1 were similar,
the relative abundances of products varied greatly. Comparison of the relative abundances
of the product ions that lost CO2 or H2O and complementary product ions resulting from
sequential four-membered hydrogen rearrangement showed that the differences were related
to the protonation sites. The loss of HF, probably though the formation of an ion=neutral
complex, is of scientiﬁc interest. The identities of the major product ions were conﬁrmed by
deuterium-labeling experiments that demonstrated an unusual loss of a deuterium atom.
The major differences in fragmentation patterns were compared to previous reports in the
literature.
Keywords: 2-N-methylated moxiﬂoxacin; Electrospray ionization time-of-ﬂight mass spectrometry;
Moxiﬂoxacin
INTRODUCTION
Quinolones are one of the most important class of antimicrobial drugs.
Because quinolones selectively inhibit bacterial DNA helicase (DNA gyrase), they
have been widely used for the treatment of bacteria prostatitis and urinary tract,
gastrointestinal, respiratory tract, skin, and soft tissue infections (Colorado and
Brodbelt 1994; Cvijovic et al. 2012). As previously reviewed (Doerge and Bajic
1995; Volmer, Mansoori, and Locke 1997; Golet et al. 2001; Schilling et al. 1996),
quinolones have been extensively studied by high-performance liquid chromatography
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(HPLC), mass spectrometry, and HPLC–tandem mass spectrometry (HPLC–MS–
MS). Fourth-generation quinolones are more effective against both Gram-positive
and Gram-negative bacteria in vitro and in vivo (Jacobsen et al. 2011; Ardila,
Ferna´ndez, and Guzma´n 2009; Galania et al. 2008; Sakka et al. 2005; Grayo et al. 2008).
Moxiﬂoxacin (1-cyclopropyl-7-[(1S, 6S)-2, 8-diazabicyclo[4.3.0]non-8-yl]-6-
ﬂuoro-8-methoxy-4-oxo-quinoline-3-carboxylic acid) is a fourth-generation quino-
lone that has attracted the attention of chemists, as its pharmacokinetics and
in vivo metabolism have been been thoroughly investigated (Vishwanathan, Bartlett,
and Stewart 2002; Vu et al. 2011; Sultana et al. 2010; Xu et al. 2010; Hemanth et al.
2011). Raju et al. (2012) recently determined the fragmentation pathways of moxi-
ﬂoxacin by electrospray ionization (ESI)-quadrupole ion trap mass spectrometry
and ESI-quadrupole-time-of-ﬂight (QTOF). Unexpectedly, in studying this com-
pound, a different tandem mass spectrum spectrum using ESI-QTOF was deter-
mined. To obtain reliable structural information on these compounds, tandem
mass spectra of moxiﬂoxacin, 2-N-methylated moxiﬂoxacin (analog 1), and
1-cyclopropyl-6, 7-diﬂuoro-8-methoxy-4-oxo-3-quinolinecarboxylic acid (analog 2)
(Figure 1) were obtained by ESI-QTOF.
EXPERIMENTAL
Chemicals and Samples
Moxiﬂoxacin, 2-N methylmoxiﬂoxacin, and 1-cyclopropyl-6,7-diﬂuoro-8-
methoxy-4-oxo-quinoline-3-carboxylic acid (purity: 98%) were obtained from Yao
Pharma (Chongqing, China). High-performance liquid chromatography-grade
methanol and the mass calibration standard were purchased from Fisher Scientiﬁc
(Pittsburgh, PA, USA) and Agilent Technologies (Santa Clara, CA, USA),
respectively. Deuterated methanol was were procured from Cambridge Isotope
Laboratories (Andover, MA).
Mass Spectrometry
Mass spectrometry was performed on a Bruker mirOTOF-Q (Bremen,
Germany) equipped with an ESI source in the positive mode. The mass resolution
was 10,000 full width at half maximum. Argon was used as the collision gas and
high-purity nitrogen gas was employed as the nebulizer and drying gases at ﬂow rates
of 0.3 Bar and 4.0 L=min, respectively. The ESI source conditions were as follows:
capillary voltage, 4500V; end plate voltage, 4000V; capillary exit voltage,
120V; and drying gas temperature, 180C. The collision energy was optimized to
Figure 1. Structures of moxiﬂoxacin (left, Mr 401.1751), analog 1 (middle, Mr 415.1907), and analog 2
(right, Mr 295.0656).
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achieve sufﬁcient fragmentation of the selected precursor ion. The samples were
dissolved in methanol and the diluent was directly injected into the mass spec-
trometer. The hydrogen=deuterium (H=D) exchange experiments were performed
by incubation of moxiﬂoxacin and 2-N methylmoxiﬂoxacin in 200 mL CD3OD for
1 h to obtain the deuterated samples. The mass spectral were processed with Bruker
Compass DataAnalysis 4.0 software.
RESULTS AND DISCUSSION
The protonated molecule, [MþH]þ at m=z 402 for moxiﬂoxacin was selected as
the precursor ion for the collision-induced dissociation (CID) tandem mass spectral
analysis. The product ions are shown in Figure 2(a) and the accurate masses and
elemental compositions of the major product ions are listed in Table 1. The proposed
major fragmentation pathways of protonated moxiﬂoxacin are shown in Scheme 1.
The neutral losses of HF, H2O, HCOOH, and CH3 are important fragmentation
patterns. The product ion at m=z 382, resulting from the loss of HF from [MþH]þ
Figure 2. Electrospray ionization tandem mass spectra of (a) protonated moxiﬂoxacin at m=z 402 and
(b) protonated analog 1 at m=z 416. The inserts show the masses of product ions with a low abundance
(collision energy of 34 eV).
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at m=z 402 yields the product ion at m=z 364 through the loss of H2O. The loss of
a HF molecule may undergo ion=neutral complex processes (Chai et al. 2011). The
product ion at m=z 341 is formed from m=z 382 by cleavage of the ﬁve-membered
heterocycle (Figure S1), which is consistent with ion=neutral complex formation.
Notably, a pair of complementary product ions at m=z 293 and 110 resulted from
a proton-bound complex (Zhang et al. 2012) formed by sequential four-membered
hydrogen rearrangement (Hudson and McAdoo 2007; Kingston et al. 1975) from
m=z 402. The product ion at m=z 293 yielded abundant product ions at m=z 278
and 260 by loss of CH3 and H2O or a combination of the two (Scheme 1).
Interestingly, many of the abundant product ions at m=z 298, 278, 260, and 232 were
radicals (Cai, Mo, and Rannulu 2010; Xu et al. 2012; Wu et al. 2012).
The fragmentation pathways of protonated moxiﬂoxacin were different from
those reported by Raju et al. (2012), although the analyses were performed with
Table 1. Elemental compositions of the major product ions from [MþH]þ for moxiﬂoxacin (collision
energy of 34 eV)
Ion Formula
Calculated
mass
Observed
mass
Error
(ppm)
[MþH]þ C21H25FN3O4 402.1824 402.1814 2.4
[MþH–H2O]þ C21H23FN3O3 384.1718 384.1718 0.0
[MþH–HF]þ C21H24N3O4 382.1761 382.1751 2.8
[MþH–CO2]þ C20H25FN3O2 358.1925 358.1921 1.1
[MþH–HF–C2H3N]þ C19H21N2O4 341.1496 341.1493 0.8
[MþH–CO2–C2H3NH2–CH3]þ C17H15FN2O2 298.1112 298.1111 0.3
[MþH–C7H11N]þ (b–H rearrangement) C14H14FN2O4 293.0932 293.0939 2.5
[MþH–C7H11N–CH3]þ C16H10N2O3 278.0697 278.0696 0.3
[MþH–C7H11N–CH3–H2O]þ C13H9FN2O3 260.0592 260.0601 3.3
[MþH–HF–CH3–C7H10N2]þ C13H11NO4 245.0683 245.0676 2.7
[MþH–C7H11N–CH3–H2O–CO]þ C12H9FN2O2 232.0643 232.0640 1.2
[MþH–C6H11N–HCOOH–C3H4]þ C11H8FN2O2 219.0564 219.0566 0.9
[MþH–CO2–C6H11N–CH3–C3H5]þ C10H6FN2O2 205.0408 205.0410 1.3
[C7H11N þH]þ (b–H rearrangement) C7H12N 110.0964 110.0963 1.0
Table 2. Elemental compositions of major product ions from [MþH]þ for analog 1 (collision energy
of 34 eV)
Ion Formula
Calculated
mass
Observed
mass
Error
(ppm)
[MþH]þ C22H27FN3O4 416.1980 416.1992 3.0
[MþH–CO2]þ C21H27FN3O2 372.2082 372.2088 1.5
[MþH–C3H4–CH4]þ C17H19FN3O2 316.1456 316.1447 2.9
[MþH–CO2–C7H13N]þ C14H14FN2O2 261.1034 261.1042 2.9
[MþH–CO2–C7H13N –CH3]þ C13H11FN2O2 246.0799 246.0807 3.2
[MþH–CO2–C7H13N –CH2O]þ C13H12FN2O 231.0928 231.0923 2.1
[MþH–C7H13N–HCOOH– C3H4]þ C11H8FN2O2 219.0564 219.0591 12
[MþH–CO2–C7H13N–CH3– C3H5]þ C10H6FN2O2 205.0408 205.0416 4.2
[C8H13N þH]þ C8H14N 124.1121 124.1116 4.2
[C7H12N]
þ C7H12N 110.0964 110.0960 3.7
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instruments from different manufacturers. The losses of neutral species, such as CO,
H2O, CO2, and HF, and the cleavage of piperidine or pyrrolidine occurred in both
studies. However, the relative abundances of the product ions resulting from the
same fragmentation patterns varied greatly. Raju et al. (2012) reported several
characteristic ions formed by cleavage of the benzene ring, whereas negligible
amounts of these products were observed in this analysis. Many abundant radical
ions resulting from loss of CH3 or CH3O were detected in this work, although Raju
et al. (2012) observed small numbers of these ions.
Although the structures of moxiﬂoxacin and analog 1 are similar, the relative
abundances of products from the same fragmentation patterns varied greatly
(Figure 2 and Table 2). The abundances of the product ion at m=z 384 formed by
the loss of H2O and the product ion at m=z 260 resulting from the four-membered
hydrogen rearrangement are high in the tandem mass spectrum of moxiﬂoxacin,
whereas the abundances of m=z 358 formed by loss of CO2 and m=z 110 resulting
from four-membered H rearrangement were low. The opposite was observed for
analog 1. The abundances of the product ions at m=z 372 formed by the loss of
CO2 from [MþH]þ at m=z 416 and m=z 124 formed by four-membered H rearrange-
ment were high [Scheme 2 and Figure 2(b)]. Analog 2 readily lost H2O, although the
product at m=z 252 formed by the loss of CO2 was not detected (Figure 3). The frag-
mentation information obtained from these compounds, suggests that these com-
pounds are protonated at different sites, which affects the fragmentation
pathways. When the proton is located at a tertiary amine on piperidine, loss of
CO2 occurs. However, it forms six-membered ring by hydrogen bond with two oxy-
gen atoms and loss of H2O occurs readily. The peak for the species formed by the
loss of CO2 was large for analog 1, small for moxiﬂoxacin, and absent for analog
2. These results are consistent with those reported by Neta et al. (2010). The
high-abundance product ion at m=z 261 in the tandem mass spectrum of analog 1
is formed by the four-membered H rearrangement and McLafferty-type rearrange-
ment (Gross and Veith 1994) from m=z 372 (Scheme 2). The differences in the frag-
mentation patterns for analog 1 between this study and the study published by Raju
Scheme 1. Proposed fragmentation pathways for protonated moxiﬂoxacin.
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et al. (2012) are similar to those for moxiﬂoxacin. For analog 2, the retro Diels-Alder
(RDA) reaction and loss of three-numbered ring, CO, H2O, and CH3 were the major
fragmentation patterns. The high-abundance radical ion at m=z 235 (Figure 3)
resulted from the protonated molecule, [MþH]þ at m=z 296, by the sequential loss
of CO, H2O, and CH3 (Figure S2). The product ion at m=z 254 was formed by
the loss of a three-numbered ring (C3H6). The radical ion at m=z 195 was formed
by retro Diels-Alder reaction, accompanied by the loss of CH3O.
Labeling experiments involving hydrogen–deuterium exchange in moxiﬂoxacin
and analog 1 were performed and the corresponding tandem mass spectra are
shown in Figure 4. An unexpected loss of the deuterium atom was detected. The high
resolution deuterium-labeled spectra (Figure S3) support this unexpected loss.
The high-abundance product ions at m=z 403 and 416 were formed by the loss
of a deuterium atom from precursor ions at m=z 405 and 418, respectively. The
Scheme 2. Proposed fragmentation pathways for protonated analog 1.
Figure 3. Electrospray ionization tandem mass spectra of analog 2 at m=z 296 (collision energy of 23 eV).
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deuterium-labeling experiments also indicated that the product ions at m=z 110
and 124 in the tandem mass spectra of moxiﬂoxacin and analog 1 may have two
structures (Figure S1). Other product ions in the deuterium-labelled spectra
supported the proposed fragmentation pathways.
CONCLUSIONS
The collision induced dissociation of moxiﬂoxacin and its 2-N methyl
substitute were clariﬁed using by electrosprary ionization quadrupole time-of-ﬂight
tandem mass spectrometry in the positive-ion mode. Many unusual radical ions were
detected in the mass spectrum of moxiﬂoxacin. Although the structure of analog 1 is
similar to that of moxiﬂoxacin, the relative abundances of product ions from the
same fragmentation patterns varied greatly. The protonation sites were tentatively
Figure 4. Electrospray ionization tandem mass spectra of (a) deutreated moxiﬂoxacin at m=z 405 (collision
energy of 32 eV) and (b) deutreated analog 1 at m=z 418 (collision energy of 27 eV). The insert shows the
masses of product ions with low abundances.
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determined by comparing the relative abundances of the peaks resulting from the
loss of CO2, or H2O, and complementary product ions arising from a sequential
four-membered H rearrangement. In addition, the unexpected loss of a deuterium
atom was observed in the labeling experiments. In summary, the inﬂuence of proto-
nation sites on fragmentation and characteristic fragmentation patterns, such as the
loss of HF and radicals, are of scientiﬁc interest. The information obtained from the
fragmentation experiments allows rapid identiﬁcation of these compounds and their
metabolites in complex matrices.
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